Table 2.
In utero Measures of Urinary BPA and Phthalate Metabolites (n=115) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ln Estradiol | ln Testosterone | ln SHBG | ln DHEA-S | ln Inhibin B | |||||||||||
% Change | 95%CI | p-value | % Change | 95%CI | p-value | % Change | 95%CI | p-value | % Change | 95%CI | p-value | % Change | 95%CI | p-value | |
|
|
|
|
|
|||||||||||
ln MEHP | 10.0 | −4.5, 26.6 | 0.19 | −7.2 | −28.1, 19.9 | 0.57 | −5.4 | −15.7, 6.0 | 0.33 | 29.1 | 9.2, 52.6 | 0.003 | 22.5 | 0.9, 48.7 | 0.04 |
ln MEHHP | 8.3 | −6.1, 24.9 | 0.27 | 3.3 | −20.2, 33.8 | 0.80 | −3.2 | −13.8, 8.7 | 0.58 | 19.2 | 0.3, 41.6 | 0.05 | 17.3 | −3.7, 42.8 | 0.11 |
ln MEOHP | 8.6 | −6.4, 25.9 | 0.28 | 4.6 | −20.1, 36.9 | 0.74 | −4.8 | −15.6, 7.4 | 0.42 | 23.5 | 3.3, 47.6 | 0.02 | 18.4 | −3.6, 45.3 | 0.11 |
ln MECPP | 11.8 | −3.4, 29.3 | 0.13 | 0.4 | −23.0, 30.9 | 0.98 | −4.5 | −15.1, 7.5 | 0.44 | 24.1 | 4.2, 47.9 | 0.02 | 22.5 | 0.3, 49.7 | 0.05 |
ln MBzP | −2.7 | −13.8, 9.7 | 0.65 | 28.9 | 4.3, 59.3 | 0.02 | −1.7 | −10.8, 8.4 | 0.73 | 0.0 | −13.7, 15.9 | 1.00 | 0.4 | −15.1, 18.6 | 0.97 |
ln MnBP | 0.6 | −12.0, 15.0 | 0.93 | 12.4 | −11.6, 42.8 | 0.34 | −1.4 | −11.4, 9.9 | 0.80 | 18.8 | 1.2, 39.4 | 0.04 | −1.7 | −18.4, 18.3 | 0.85 |
ln MiBP | 6.9 | −7.0, 23.0 | 0.34 | 17.4 | −8.6, 50.8 | 0.21 | −0.4 | −11.0, 11.5 | 0.95 | 19.5 | 1.0, 41.3 | 0.04 | 4.5 | −13.9, 26.9 | 0.65 |
ln MCPP | 3.6 | −11.0, 20.6 | 0.65 | 7.0 | −18.6, 40.7 | 0.62 | −3.2 | −14.4, 9.4 | 0.60 | 21.5 | 1.2, 45.8 | 0.04 | 12.1 | −9.1, 38.3 | 0.28 |
ln MEP | 1.1 | −10.0, 13.6 | 0.85 | 25.5 | 2.1, 54.1 | 0.03 | −4.1 | −12.6, 5.4 | 0.38 | 10.8 | −3.8, 27.6 | 0.15 | 7.9 | −8.1, 26.8 | 0.35 |
ln BPA | −4.4 | −26.0, 23.5 | 0.73 | 2.0 | −35.7, 61.8 | 0.93 | −7.1 | −24.4, 14.2 | 0.48 | 20.9 | −11.4, 65.1 | 0.23 | 6.5 | −25.3, 52.0 | 0.72 |
Peripubertal Measures of Urinary BPA and Phthalate Metabolites (n=128) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ln Estradiol | ln Testosterone | ln SHBG | ln DHEA-S | ln Inhibin B | |||||||||||
% Change | 95%CI | p-value | % Change | 95%CI | p-value | % Change | 95%CI | p-value | % Change | 95%CI | p-value | % Change | 95%CI | p-value | |
|
|
|
|
|
|||||||||||
ln MEHP | −0.3 | −13.3, 14.6 | 0.96 | −4.1 | −24.2, 21.4 | 0.73 | 2.7 | −8.4, 15.3 | 0.64 | −1.8 | −16.6, 15.7 | 0.83 | −0.7 | −18.3, 20.7 | 0.94 |
ln MEHHP | 4.5 | −10.9, 22.5 | 0.59 | 4.8 | −19.9, 37.2 | 0.73 | 2.6 | −10.1, 17.0 | 0.70 | −11.2 | −26.3, 6.9 | 0.21 | 2.4 | −18.1, 28.0 | 0.83 |
ln MEOHP | 6.2 | −8.7, 23.6 | 0.43 | 5.0 | −18.7, 35.5 | 0.71 | 4.3 | −7.9, 18.2 | 0.50 | −10.1 | −24.6, 7.3 | 0.24 | 8.6 | −12.1, 34.2 | 0.44 |
ln MECPP | 5.9 | −8.7, 22.9 | 0.45 | −10.0 | −30.0, 15.7 | 0.41 | 3.6 | −8.4, 17.1 | 0.57 | −11.9 | −25.9, 4.8 | 0.15 | 1.6 | −17.5, 25.2 | 0.88 |
ln MBzP | 3.3 | −9.8, 18.2 | 0.64 | 15.7 | −7.8, 45.2 | 0.21 | 14.4 | 2.6, 27.6 | 0.02 | −10.6 | −23.6, 4.7 | 0.16 | 1.4 | −16.1, 22.5 | 0.89 |
ln MnBP | 2.6 | −10.5, 17.7 | 0.71 | 0.8 | −20.0, 26.9 | 0.95 | 4.2 | −6.9, 16.7 | 0.47 | −3.3 | −17.7, 13.5 | 0.68 | −7.7 | −23.7, 11.8 | 0.41 |
ln MiBP | 14.2 | −1.3, 32.2 | 0.07 | 7.5 | −16.2, 37.9 | 0.57 | 4.9 | −7.1, 18.5 | 0.44 | −2.2 | −17.7, 16.4 | 0.80 | −2.7 | −20.9, 19.7 | 0.79 |
ln MCPP | −2.5 | −15.0, 11.8 | 0.71 | −10.1 | −28.6, 13.2 | 0.36 | 9.2 | −2.3, 22.1 | 0.12 | −7.2 | −20.9, 8.9 | 0.36 | −7.0 | −23.2, 12.6 | 0.45 |
ln MEP | −3.8 | −16.0, 10.1 | 0.57 | 17.0 | −6.6, 46.7 | 0.17 | 3.8 | −7.1, 16.0 | 0.50 | −8.8 | −22.1, 6.8 | 0.25 | −14.0 | −28.6, 3.7 | 0.11 |
ln BPA | −5.0 | −19.6, 12.2 | 0.54 | 10.7 | −16.4, 46.7 | 0.47 | −3.2 | −15.6, 11.1 | 0.65 | −1.9 | −19.3, 19.3 | 0.85 | 15.9 | −8.1, 46.2 | 0.21 |
CI, confidence interval